Treatment of chronic hepatitis C with α-interferon plus ofloxacin in patients not responding to α-interferon alone
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (3) , 369-374
- https://doi.org/10.1016/s0168-8278(98)80053-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Failure of Ketoprofen and Interferon Combination Therapy to Improve Interferon‐Resistant Chronic Hepatitis CCanadian Journal of Gastroenterology and Hepatology, 1997
- Liver transplantation for hepatitis C: The promise and the challengeHepatology, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis CGastroenterology, 1994
- N-Acetyl Cysteine Enhances the Response to Interferon-α in Chronic Hepatitis C: A Pilot StudyJournal of Interferon Research, 1993
- Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferonAntimicrobial Agents and Chemotherapy, 1993
- Long-Term Mortality after Transfusion-Associated Non-A, Non-B HepatitisNew England Journal of Medicine, 1992